Apolipoproteins are protein constituents of lipoproteins that transport cholesterol and fat in
circulation and are central to cardiovascular health and disease. Soluble apolipoproteins …

Circulating low-density lipoprotein (LDL) particles enter the arterial intima where they bind to
the extracellular matrix and become modified by lipases, proteases, and oxidizing enzymes …

Understanding the interface between nanomaterials and lipoproteins is crucial for gaining
insights into their impact on lipoprotein structure and lipid metabolism. Here, we use …

Electronegative low-density lipoprotein (LDL)(LDL (−)), a modified LDL that is present in
blood and exerts atherogenic effects on endothelial cells and monocytes. This study aimed …

Low-density lipoproteins (LDLs, also known as 'bad cholesterol') are the major carriers of
circulating cholesterol and the main causative risk factor of atherosclerosis. Plasma LDLs …

Electronegative low density lipoprotein (LDL (−)) is a minor modified fraction of LDL found in
blood. It comprises a heterogeneous population of LDL particles modified by various …

Neutrophil extracellular traps (NETs) significantly contribute to various pathophysiological
conditions, including cardiovascular diseases. NET formation in the vasculature exhibits …

Abstract Background: Electronegative LDL (LDL (−)), a modified LDL fraction found in blood,
induces the release of inflammatory mediators in endothelial cells and leukocytes. However …

LDL (−) could play a relevant role in atherogenesis by acting as a priming factor that
stimulates lipoprotein aggregation. This process, which appears to be mediated by a PLC …

Atherosclerosis is one of the leading causes of death in developed and developing
countries. The atherogenicity phenomenon cannot be separated from the role of modified …